|
1
|
Lin JT: Screening of gastric cancer: Who,
when, and how. Clin Gastroenterol Hepatol. 12:135–138. 2014.
View Article : Google Scholar
|
|
2
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar
|
|
3
|
Kim YN, Koo KH, Sung JY, Yun UJ and Kim H:
Anoikis resistance: An essential prerequisite for tumor metastasis.
Int J Cell Biol. 2012:3068792012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tan K, Goldstein D, Crowe P and Yang JL:
Uncovering a key to the process of metastasis in human cancers: A
review of critical regulators of anoikis. J Cancer Res Clin Oncol.
139:1795–1805. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Paoli P, Giannoni E and Chiarugi P:
Anoikis molecular pathways and its role in cancer progression.
Biochim Biophys Acta. 1833:3481–3498. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zannini L, Buscemi G, Kim JE, Fontanella E
and Delia D: DBC1 phosphorylation by ATM/ATR inhibits SIRT1
deacetylase in response to DNA damage. J Mol Cell Biol. 4:294–303.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Park SH, Riley P IV and Frisch SM:
Regulation of anoikis by deleted in breast cancer-1 (DBC1) through
NF-κB. Apoptosis. 18:949–962. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang Y, Gu Y, Sha S, Kong X, Zhu H, Xu B,
Li Y and Wu K: DBC1 is overexpressed and associated with poor
prognosis in colorectal cancer. Int J Clin Oncol. 19:106–112. 2014.
View Article : Google Scholar
|
|
9
|
Kim SH, Kim JH, Yu EJ, Lee KW and Park CK:
The over-expression of DBC1 in esophageal squamous cell carcinoma
correlates with poor prognosis. Histol Histopathol. 27:49–58.
2012.
|
|
10
|
Lee H, Kim KR, Noh SJ, Park HS, Kwon KS,
Park BH, Jung SH, Youn HJ, Lee BK, Chung MJ, et al: Expression of
DBC1 and SIRT1 is associated with poor prognosis for breast
carcinoma. Hum Pathol. 42:204–213. 2011. View Article : Google Scholar
|
|
11
|
Hiraike H, Wada-Hiraike O, Nakagawa S,
Saji S, Maeda D, Miyamoto Y, Sone K, Tanikawa M, Oda K, Nakagawa K,
et al: Expression of DBC1 is associated with nuclear grade and HER2
expression in breast cancer. Exp Ther Med. 2:1105–1109. 2011.
|
|
12
|
Zhao W, Kruse JP, Tang Y, Jung SY, Qin J
and Gu W: Negative regulation of the deacetylase SIRT1 by DBC1.
Nature. 451:587–590. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kim JE, Chen J and Lou Z: DBC1 is a
negative regulator of SIRT1. Nature. 451:583–586. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hiraike H, Wada-Hiraike O, Nakagawa S,
Koyama S, Miyamoto Y, Sone K, Tanikawa M, Tsuruga T, Nagasaka K,
Matsumoto Y, et al: Identification of DBC1 as a transcriptional
repressor for BRCA1. Br J Cancer. 102:1061–1067. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Koyama S, Wada-Hiraike O, Nakagawa S,
Tanikawa M, Hiraike H, Miyamoto Y, Sone K, Oda K, Fukuhara H,
Nakagawa K, et al: Repression of estrogen receptor beta function by
putative tumor suppressor DBC1. Biochem Biophys Res Commun.
392:357–362. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Schafer ZT, Grassian AR, Song L, Jiang Z,
Gerhart-Hines Z, Irie HY, Gao S, Puigserver P and Brugge JS:
Antioxidant and oncogene rescue of metabolic defects caused by loss
of matrix attachment. Nature. 461:109–113. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang YF, Zhang AR, Zhang BC, Rao ZG, Gao
JF, Lv MH, Wu YY, Wang SM, Wang RQ and Fang DC: MiR-26a regulates
cell cycle and anoikis of human esophageal adenocarcinoma cells
through Rb1-E2F1 signaling pathway. Mol Biol Rep. 40:1711–1720.
2013. View Article : Google Scholar
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
19
|
Rauert-Wunderlich H, Siegmund D, Maier E,
Giner T, Bargou RC, Wajant H and Stühmer T: The IKK inhibitor Bay
11-7082 induces cell death independent from inhibition of
activation of NFκB transcription factors. PLoS One. 8:e592922013.
View Article : Google Scholar
|
|
20
|
Liu SF, Ye X and Malik AB: Inhibition of
NF-kappaB activation by pyrrolidine dithiocarbamate prevents in
vivo expression of proinflammatory genes. Circulation.
100:1330–1337. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Oztürk S, Schleich K and Lavrik IN:
Cellular FLICE-like inhibitory proteins (c-FLIPs): Fine-tuners of
life and death decisions. Exp Cell Res. 318:1324–1331. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Luqman S and Pezzuto JM: NFkappaB: A
promising target for natural products in cancer chemoprevention.
Phytother Res. 24:949–963. 2010.PubMed/NCBI
|
|
23
|
Hamaguchi M, Meth JL, von Klitzing C, Wei
W, Esposito D, Rodgers L, Walsh T, Welcsh P, King MC and Wigler MH:
DBC2, a candidate for a tumor suppressor gene involved in breast
cancer. Proc Natl Acad Sci USA. 99:13647–13652. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Trauernicht AM, Kim SJ, Kim NH, Clarke R
and Boyer TG: DBC-1 mediates endocrine resistant breast cancer cell
survival. Cell Cycle. 9:1218–1219. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Trauernicht AM, Kim SJ, Kim NH and Boyer
TG: Modulation of estrogen receptor alpha protein level and
survival function by DBC-1. Mol Endocrinol. 21:1526–1536. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kim JE and Sung S: Deleted in breast
cancer 1 (DBC1) is a dynamically regulated protein. Neoplasma.
57:365–368. 2010.PubMed/NCBI
|
|
27
|
Garapaty S, Xu CF, Trojer P, Mahajan MA,
Neubert TA and Samuels HH: Identification and characterization of a
novel nuclear protein complex involved in nuclear hormone
receptor-mediated gene regulation. J Biol Chem. 284:7542–7552.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Fu J, Jiang J, Li J, Wang S, Shi G, Feng
Q, White E, Qin J and Wong J: Deleted in breast cancer 1, a novel
androgen receptor (AR) coactivator that promotes AR DNA-binding
activity. J Biol Chem. 284:6832–6840. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kim JR, Moon YJ, Kwon KS, Bae JS, Wagle S,
Yu TK, Kim KM, Park HS, Lee JH, Moon WS, et al: Expression of SIRT1
and DBC1 is associated with poor prognosis of soft tissue sarcomas.
PLoS One. 8:e747382013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Park HS, Bae JS, Noh SJ, Kim KM, Lee H,
Moon WS, Chung MJ, Kang MJ, Lee DG and Jang KY: Expression of DBC1
and Androgen Receptor Predict Poor Prognosis in Diffuse Large B
Cell Lymphoma. Transl Oncol. 6:370–81. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kang Y, Jung WY, Lee H, Lee E, Kim A and
Kim BH: Expression of SIRT1 and DBC1 in gastric adenocarcinoma.
Korean J Pathol. 46:523–531. 2012. View Article : Google Scholar
|
|
32
|
Cha EJ, Noh SJ, Kwon KS, Kim CY, Park BH,
Park HS, Lee H, Chung MJ, Kang MJ, Lee DG, et al: Expression of
DBC1 and SIRT1 is associated with poor prognosis of gastric
carcinoma. Clin Cancer Res. 15:4453–4459. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Guadamillas MC, Cerezo A and Del Pozo MA:
Overcoming anoikis-pathways to anchorage-independent growth in
cancer. J Cell Sci. 124:3189–3197. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Aggarwal BB and Sung B: NF-κB in cancer: A
matter of life and death. Cancer Discov. 1:469–471. 2011.
View Article : Google Scholar
|
|
35
|
DiDonato JA, Mercurio F and Karin M: NF-κB
and the link between inflammation and cancer. Immunol Rev.
246:379–400. 2012. View Article : Google Scholar : PubMed/NCBI
|
